US$ 29.56
bpc-157 clinical trials human evidence review safety regulatory status BPC-157 bpc-157 human clinical trials evidence
Description
The benzyl alcohol acts as a preservative: it prevents bacteria and other microorganisms from growing in the solution after it is opened

Lavery, D

This adds cost but may be worthwhile for expensive peptides like SS-31 where counterfeit or degraded product represents significant financial loss

It stops the leaking

The highest dose studied in Phase 2, producing up to 24.2% average weight loss at 48 weeks

Reduced Contamination Risk: By using TB500 BPC157 20mg Pre Mixed Pen, the risk of contamination is minimised, ensuring the integrity of the peptides for research purposes
